Clinical Trial Update: Pueraria Lobata and Pueraria Thomsonii for Mild Dyslipidemia [NA]

View source ↗

Summary

This clinical trial update reports a completed study evaluating Pueraria lobata and Pueraria Thomsonii for mild dyslipidemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemias

Drugs mentioned

• Pueraria Thomsonii
• Pueraria lobata

Snippet

Sponsor: Jiangxi University of Traditional Chinese Medicine | Conditions: Dyslipidemias | NA | Status: COMPLETED